featured
Hydrocortisone Plus Fludrocortisone for Treating Patients With Community-Acquired Pneumonia–Related Septic Shock
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial
Lancet Respir Med 2024 Feb 01;[EPub Ahead of Print], N Heming, A Renault, E Kuperminc, C Brun-Buisson, B Megarbane, JP Quenot, S Siami, A Cariou, X Forceville, C Schwebel, M Leone, JF Timsit, B Misset, MA Benali, G Colin, B Souweine, K Asehnoune, E Mercier, L Chimot, C Charpentier, B François, T Boulain, F Petitpas, JM Constantin, G Dhonneur, F Baudin, A Combes, J Bohé, JF Loriferne, F Cook, M Slama, O Leroy, G Capellier, A Dargent, T Hissem, R Bounab, V Maxime, P Moine, E Bellissant, D AnnaneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.